InMode expects preliminary second-quarter 2026 revenue to range between $95.2 million and $95.4 million. This figure surpasses the analyst consensus estimate of $92.6 million. The company will release its full second-quarter financial results before market open on August 5, 2026.
The medical technology provider reiterated its full-year 2026 revenue guidance. Guidance remains in the range of $365 million to $375 million. InMode will not host an investor conference call as its Special Committee continues to evaluate strategic proposals.